• Services
  • Bengaluru
  • 13 views
Reference: 99190

Location: Bengaluru

Price: Contact us

finasteride tablets online France

Hair Care Products: Finasteride, Minoxidil, Dutasteride & Hair Loss Treatments

Hair loss is rarely one condition with one cause. Androgenetic alopecia (pattern baldness), telogen effluvium (stress- or illness-triggered shedding), and alopecia areata (autoimmune patchy loss) each work through a different mechanism, and the medicines that treat one do little for another. Pinkline Exports' Hair Care category is organized around that distinction, supplying DHT-blocking tablets, minoxidil in both oral and topical form, combination solutions, nutraceutical support, and a JAK1-inhibitor option to licensed pharmacies and clinics across the USA, UK, Australia, and other global markets.

Rather than a single "hair growth" product line, this category is built molecule by molecule: finasteride and dutasteride block the DHT that drives pattern hair loss, minoxidil works through vasodilation and a prolonged growth phase regardless of hormone levels, and abrocitinib (Cibinqo) addresses the inflammatory pathway relevant to autoimmune hair loss. Knowing which mechanism fits which type of shedding is the difference between a product that works and one that doesn't.

What is Hair Care?

In a pharmaceutical context, hair care is the use of specific active compounds to interrupt the biological process behind hair loss, rather than general grooming or cosmetic upkeep. The three core mechanisms stocked in this category are 5-alpha reductase inhibition (finasteride, dutasteride), vasodilation and anagen-phase extension (minoxidil, oral and topical), and JAK1 inhibition for inflammatory, autoimmune-pattern hair loss (abrocitinib).

Matching the mechanism to the diagnosis matters more than matching a product to a symptom. A DHT-blocker will not help alopecia areata, and a JAK inhibitor has no established role in ordinary male pattern baldness. Buyers stocking this category benefit from carrying products across all three mechanisms so prescribers can match treatment to the specific type of hair loss a patient presents with.